Sepsis-Induced Purpura Fulminans Management
Initial Management
- The Society of Critical Care Medicine recommends beginning immediate broad-spectrum antibiotics within the first hour of recognition of septic shock 1
- For E. coli sepsis with purpura fulminans, the Infectious Diseases Society of America suggests using meropenem, imipenem/cilastin, or piperacillin/tazobactam as first-line therapy 2
- Consider combination therapy with an aminoglycoside for severe sepsis, as recommended by the American College of Chest Physicians 2, 1
- Obtain at least two sets of blood cultures before starting antibiotics, as advised by the Infectious Diseases Society of America 1
Hemodynamic Support
- The American College of Cardiology recommends administering aggressive fluid resuscitation with crystalloids or colloids targeting mean arterial pressure ≥65 mmHg 3, 1
- Target central venous pressure 8-12 mmHg and urinary output ≥0.5 ml/kg/h, as suggested by the Society of Critical Care Medicine 2, 3
- If fluid resuscitation fails to restore adequate blood pressure, initiate vasopressors, such as norepinephrine, as recommended by the American College of Chest Physicians 3, 4
Specific Management for Purpura Fulminans
Blood Product Support
- Target hemoglobin levels between 8-9 g/dl during acute phase, as recommended by the American Association of Blood Banks 3
- Consider higher hemoglobin targets if clinically indicated or if central venous oxygen saturation is low, as suggested by the Society of Critical Care Medicine 4
- Use plasma therapies to correct sepsis-induced thrombotic disorders, including DIC and thrombotic microangiopathy, as advised by the American College of Chest Physicians 4
Surgical Considerations
- Source control, such as drainage of any purulent collections, should be performed within the first 12 hours if feasible, as recommended by the Surgical Infection Society 5
Monitoring and Ongoing Care
- Perform daily reassessment of antimicrobial therapy for potential de-escalation once culture results are available, as suggested by the Infectious Diseases Society of America 1
- Continue broad-spectrum antibiotics for 7-10 days, depending on clinical response, as recommended by the American College of Chest Physicians 5